Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
M Modan, … , A Shitrit, Z Fuchs
M Modan, … , A Shitrit, Z Fuchs
Published March 1, 1985
Citation Information: J Clin Invest. 1985;75(3):809-817. https://doi.org/10.1172/JCI111776.
View: Text | PDF
Research Article Article has an altmetric score of 13

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.

  • Text
  • PDF
Abstract

Hypertension and glucose intolerance, determined in a random population sample (n = 2,475), showed a highly significant (P less than 0.001) association from the mildest levels of both conditions, independent of the confounding effects of age, sex, obesity, and antihypertensive medications. Summary rate ratios for hypertension were 1.48 (1.18-1.87) in abnormal tolerance and 2.26 (1.69-2.84) in diabetes compared with normal tolerance. Altogether, 83.4% of the hypertensives were either glucose-intolerant or obese--both established insulin-resistant conditions. Fasting and post-load insulin levels in a representative subgroup (n = 1,241) were significantly elevated in hypertension independent of obesity, glucose intolerance, age, and antihypertensive medications. The mean increment in summed 1- and 2-h insulin levels (milliunits per liter) compared with nonobese normotensives with normal tolerance was 12 for hypertension alone, 47 for obesity alone, 52 for abnormal tolerance alone, and 124 when all three conditions were present. The prevalence of concentrations (milliequivalents per liter) of erythrocyte Na+ greater than or equal to 7.0, K+ less than 92.5, and plasma K+ greater than or equal to 4.5 in a subsample of 59 individuals with all combinations of abnormal tolerance obesity and hypertension was compared with those in 30 individuals free of these conditions. Altogether, 88.1% of the former vs. 40.0% of the latter group presented at least one of these three markers of internal cation imbalance (P less than 0.001). We conclude that insulin resistance and/or hyperinsulinemia (a) are present in the majority of hypertensives, (b) constitute a common pathophysiologic feature of obesity, glucose intolerance, and hypertension, possibly explaining their ubiquitous association, and (c) may be linked to the increased peripheral vascular resistance of hypertension, which is putatively related to elevated intracellular sodium concentration.

Authors

M Modan, H Halkin, S Almog, A Lusky, A Eshkol, M Shefi, A Shitrit, Z Fuchs

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1982 1967 Total
Citations: 2 3 5 7 15 15 11 14 13 8 15 13 19 117 9 16 19 25 23 18 25 26 25 26 43 38 61 46 42 60 68 81 67 68 38 27 38 21 8 1 1 1177
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2006 (23)

Title and authors Publication Year
The metabolic syndrome and the heart—: a considered opinion
JG Leichman, VR Lavis, D Aguilar, CR Wilson, H Taegtmeyer
Clinical Research in Cardiology 2006
Women and Ischemic Heart Disease
AA Quyyumi
Journal of the American College of Cardiology 2006
A TELEOLOGICAL VIEW OF OBESITY, DIABETES AND HYPERTENSION
L Landsberg
Clinical and Experimental Pharmacology and Physiology 2006
Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL/6J mice
R Rao, CM Hao, R Redha, DH Wasserman, OP McGuinness, MD Breyer
Diabetologia 2006
The metabolic syndrome and the heart—
JG Leichman, VR Lavis, D Aguilar, CR Wilson, H Taegtmeyer
Clinical Research in Cardiology 2006
Obesity-related cardiovascular disease: implications of obstructive sleep apnea
R Wolk, VK Somers
Diabetes, Obesity and Metabolism 2006
Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls
AK Ventura, E Loken, LL Birch
Pediatrics 2006
Development of the metabolic syndrome along the female biological life-path
M Esler, G Wiesner
Journal of Hypertension 2006
Metabolic Syndrome as a Predictor of Non-Dipping Hypertension
Z Tartan, H Uyarel, H Kasikcioglu, AT Alper, B Ozay, T Bilsel, M Gul, R Ozturk, N Cam
The Tohoku Journal of Experimental Medicine 2006
Insulin Resistance, Hyperinsulinemia, and Hypertension: An Epidemiologic Approach
PA Sarafidis, GL Bakris
Journal of the CardioMetabolic Syndrome 2006
La hipertensión arterial esencial, ¿es esencialmente metabólica?
AC Fort, JM Arribas, EA Ezquerra
Medicina Clínica 2006
Is there an estrogenic component in the metabolic syndrome?
S Starcke, G Vollmer
Genes & Nutrition 2006
Can PPARγ agonists have a role in the management of obesity-related hypertension?
VT Chetty, AM Sharma
Vascular Pharmacology 2006
Development of the metabolic syndrome along the female biological life-path:
M Esler, G Wiesner
Journal of Hypertension 2006
Disappearance of Glibenclamide-Induced Hypoglycemia in Wistar-Kyoto Rats
K Sakamoto, Y Yonoki, T Fujioka, M Matsumura, Y Mitsuta, M Sano, M Saito, T Nakahara, K Ishii
Biological & Pharmaceutical Bulletin 2006
The Metabolic Syndrome and Glucose Tolerance Status Deterioration Over 23-Year Follow-Up
RS Dankner, A Chetrit, U Goldbourt
Diabetes care 2006
The metabolic syndrome and cardiovascular disease
E Bonora
Annals of Medicine 2006
Enhanced sympathetic reactivity associates with insulin resistance in the young Zucker rat
P Ruggeri, A Brunori, CE Cogo, D Storace, FD Nardo, R Burattini
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2006
Chronic Hyperinsulinemia Enhances Adrenergic Vasoconstriction and Decreases Calcitonin Gene-Related Peptide-Containing Nerve-Mediated Vasodilation in Pithed Rats
S TAKATORI, Y ZAMAMI, M MIO, Y KUROSAKI, H KAWASAKI
Hypertension Research 2006
The Metabolic Syndrome: Time for a Critical Appraisal
R Kahn, J Buse, E Ferrannini, M Stern
2006
Obesity, sympathetic nervous system, and hypertension - are they connected?
AO Conrady
2006
Insulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
C Catena, R Lapenna, S Baroselli, E Nadalini, GL Colussi, M Novello, G Favret, A Melis, A Cavarape, LA Sechi
The Journal of clinical endocrinology and metabolism 2006
Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency
L Delasfuentes, P Soto, B Cupps, M Pasque, P Herrero, R Gropler, A Waggoner, V DAVILAROMAN
Journal of Nuclear Cardiology 2006

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Posted by 1 X users
Referenced in 8 patents
Referenced in 3 Wikipedia pages
On 1 videos
Referenced in 1 clinical guideline sources
170 readers on Mendeley
See more details